Study guide

Bronchiolitis

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

Bronchiolitis

Key Takeaways Explain This Topic AI

Routine bronchodilators are not recommended for typical bronchiolitis.

Healthy infants at least six weeks old generally need oxygen for persistent saturation below 90%.

Younger or higher-risk infants use a higher oxygen threshold, commonly below 92%.

Last updated: October 2026

Acute Bronchiolitis

Acute bronchiolitis is the single most common lower respiratory tract pathogen-driven illness during the first year of life. It is characterised by acute bronchiolar inflammation, epithelial necrosis, and dynamic airway plugging.

Pathophysiology and Aetiology

Aetiological Agents : Respiratory syncytial virus (RSV) is the culprit in 70% to 80% of cases. Other pathogens include human rhinovirus, human metapneumovirus, parainfluenza, and adenovirus.

Pathophysiology : Viral replication in the ciliated respiratory epithelial cells of terminal bronchioles results in epithelial necrosis, loss of cilia, peribronchiolar lymphocytic infiltration, and submucosal oedema. Excessive mucus production combined with shed necrotic debris forms dense luminal plugs. This produces widespread partial airway obstruction (causing air trapping and hyperinflation via a ball-valve mechanism) and complete obstruction (causing patchy resorption atelectasis). The resultant ventilation-perfusion ( V / Q V/Q V / Q ) mismatch leads to hypoxaemia.

Clinical Presentation and Disease Trajectory

Typical Demographics : Infants < 12 months < 12\text{ months} < 12 months of age, with peak severity between 2 and 6 months.

Natural History : Begins with a 2- to 3-day viral upper respiratory tract prodrome (clear rhinorrhoea, sneezing, low-grade fever). Symptoms progress downward into the lower respiratory tract over days 3 to 5 (the peak of clinical severity), characterized by a dry, persistent cough, tachypnoea, and feeding difficulty. Resolution is gradual, with cough lasting a median of 10 to 14 days (up to 3 weeks in 20% of infants).

Physical Examination :

Increased work of breathing: Subcostal and intercostal retractions, tracheal tug, and nasal flaring.

Auscultation: The diagnostic hallmark is bilateral widespread fine end-inspiratory crackles accompanied by high-pitched expiratory wheezes across all lung fields.

Feeding evaluation: In infants, tachypnoea ( R R > 60 breaths/min RR > 60\text{ breaths/min} RR > 60 breaths/min ) interferes with the suck-swallow-breathe reflex, leading to dehydration and fatigue.

High-Risk Cohorts for Severe Bronchiolitis

Infants with any of the following features carry an elevated risk of rapid decompensation, severe apnoea, and PICU admission:

Age < 6 to 8 weeks < 6\text{ to }8\text{ weeks} < 6 to 8 weeks of life.

Prematurity ( < 37 weeks < 37\text{ weeks} < 37 weeks gestational age, particularly < 32 weeks < 32\text{ weeks} < 32 weeks ).

Congenital heart disease (especially lesions with pulmonary hypertension or left-to-right shunts).

Chronic neonatal lung disease (bronchopulmonary dysplasia).

Neuromuscular weakness or congenital immunodeficiency.

Diagnostic Stewardship

In accordance with the PREDICT (Paediatric Research in Emergency Departments International Collaborative) guidelines and Australian RCH practice:

Bronchiolitis is a clinical diagnosis : Routine nasopharyngeal viral multiplex PCR swabs do not alter acute clinical management and are reserved for infection control cohorting.

No Routine Chest X-Ray : CXRs in bronchiolitis invariably show hyperinflation, flattened diaphragmatic domes, and patchy peribronchial thickening or subsegmental atelectasis. These atelectatic areas are frequently misdiagnosed as bacterial consolidation, leading to inappropriate, harmful antibiotic prescribing.

Evidence-Based Supportive Management

Bronchiolitis is a self-limiting viral infection for which no curative pharmacotherapy exists. Routine management is mainly supportive; specific intensive-care exceptions do not justify routine ward treatment:

Minimal Handling : Physical agitation significantly increases metabolic rate and oxygen consumption. Unnecessary examinations, suctioning, and investigations must be minimized.

Bronchiolitis oxygen (2025): Give oxygen for persistent saturation below 90% in otherwise healthy infants aged at least six weeks; use below 92% for infants under six weeks or with an underlying condition. Assess the whole clinical picture, not a fleeting desaturation.

Hydration and Nutritional Support :

If the infant takes ≥ 50 % \ge 50\% ≥ 50% of their normal feed volume and exhibits no severe respiratory distress, continue oral breast milk or formula in smaller, more frequent feeds.

If oral intake drops below 50 % 50\% 50% of normal , or if the infant exhibits marked tachypnoea ( R R > 60 to 70 breaths/min RR > 60\text{ to }70\text{ breaths/min} RR > 60 to 70 breaths/min ) with severe indrawing, commence nasogastric (NG) tube feeds with expressed breast milk or formula. NG feeding is physiologically superior to intravenous fluids because it maintains enteral nutrition, avoids venepuncture distress, and preserves fluid/electrolyte balance.

Intravenous fluid therapy (isotonic 0.9 % 0.9\% 0.9% sodium chloride + 5 % + 5\% + 5% glucose at 80 % 80\% 80% maintenance) is reserved for infants with severe abdominal distension, recurrent vomiting, or refractory distress requiring mechanical support.

Delivered at flow rates of 1 to 2 L/kg/min 1\text{ to }2\text{ L/kg/min} 1 to 2 L/kg/min with heated and humidified gas.

Provides low-level positive end-expiratory pressure (PEEP ≈ 2 to 4 cmH 2 O \approx 2\text{ to }4\text{ cmH}_2\text{O} ≈ 2 to 4 cmH 2 ​ O ), splints open micro-airways, washes out anatomical nasopharyngeal dead space, and reduces the work of breathing. Indicated for infants who fail low-flow oxygen or present with severe respiratory distress.

Ineffective Therapies (The "Do NOT" List) :

Bronchodilators (Salbutamol / Ipratropium) : Smooth muscle hyperplasia is not the primary mechanism of obstruction in infants under 12 months; multiple large randomized trials have shown salbutamol does not improve oxygenation, reduce admission, or shorten length of stay. Salbutamol causes tachycardia, tremors, and ventilation-perfusion mismatch.

Bronchiolitis medicines: Routine bronchodilators, corticosteroids, adrenaline and antibiotics are not recommended for uncomplicated ward/ED bronchiolitis. The 2025 guideline allows specialist consideration of combined corticosteroid and adrenaline in severe disease requiring ICU care. This exception must not become routine ward treatment.

Antibiotics : Viral aetiology renders antibacterial agents ineffective; secondary bacterial pneumonia in bronchiolitis occurs in < 1 % < 1\% < 1% of cases.

Chest Physiotherapy : Increases infant distress without clinical benefit.

Primary references (checked 7 October 2026): RCH croup ; 2025 Australasian bronchiolitis guideline ; ASCIA device availability .